Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0231
NEWS & VIEWS
|
Gastric cancer perspectives: Laparoscopic surgery and systems approach polypharmacology. |
Prof. Andreas Sendler, MD, PhD.
|
Affiliation: Direktor der Chirurgischen Universitatsklinik, Marienhospital Herne Klinikum der Ruhr-Universitat Bochum, Holkeskampring 40, 44625, Herne, Germany.
E-mail : Andreas.Sendler@ruhr-uni-bochum.de |
Since there is no abstract available we provide the first paragraph.
With standardization of D2 surgery and systemic treatment with chemotherapy and targeted therapy with trastuzumab for HER2 (Human Epidermal Growth Factor Receptor 2)-positive gastric cancer, there is an end of this conventional medicine era. Now, two new scientific directions are being shaped: laparoscopic surgery for improving quality-of-life and systems pharmacology based on genome integrative analysis. Challenges and potential of this genomic medicine are discussed.
(Citation: Gastric & Breast Cancer 2012; 11(3): 146-148)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
